September 22, 2016 / 2:43 PM / 10 months ago

BRIEF-Kleo Pharmaceuticals appoints David A. Spiegel as CEO

1 Min Read

Sept 22 (Reuters) - Portage Biotech Inc

* Kleo Pharmaceuticals Inc. appoints David A. Spiegel as chief executive officer

* Says Spiegel will also serve on company's Board of directors Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below